BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/9/2026 7:28:41 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-31 05:43 |
|
Peer-Review Started |
|
2026-03-31 05:49 |
|
First Decision by Editorial Office Director |
|
2026-04-21 09:50 |
|
Return for Revision |
|
2026-04-21 09:50 |
|
Revised |
|
2026-05-10 19:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-06-12 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-12 06:28 |
|
Articles in Press |
|
2026-06-12 06:28 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-30 10:25 |
|
Publish the Manuscript Online |
|
2026-07-09 07:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Minireviews |
| Article Title |
What bariatric surgery can teach us about glucagon-like peptide-1 agonist weight loss therapy: Improving long-term outcomes and patient care
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arianna Sze Huey Tan, Tamer Saafan Moustafa Saafan, Fouad Ashoush and Kamal Mahawar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tamer Saafan Moustafa Saafan, FRCS, Upper GI Surgery, South Tyneside and Sunderland NHS Foundation Trust, Harton Ln, Sunderland SR4 7TP, United Kingdom. tsaafan@gmail.com |
| Key Words |
Bariatric surgery; Glucagon-like peptide-1 receptor agonists; Micronutrient deficiencies; Protein intake; Skeletal muscle mass; Ursodeoxycholic acid; Body image; Self-harm and suicide; Patient education; Alcohol intake |
| Core Tip |
Obesity is a prevalent chronic disease associated with significant metabolic and psychosocial morbidity. While metabolic bariatric surgery (MBS) remains the most effective treatment, incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists, are increasingly used. However, these agents are relatively new, with limited long-term data and risks related to rapid weight loss, including nutritional deficiencies, lean mass loss, and psychosocial effects-well recognised in bariatric practice. Unlike MBS, which benefits from structured follow-up and multidisciplinary care, pharmacotherapy pathways often lack equivalent monitoring and support. This review explores how bariatric principles can improve the safety and long-term outcomes of anti-obesity medication use. |
| Publish Date |
2026-07-09 07:28 |
| Citation |
Tan ASH, Saafan TSM, Ashoush F, Mahawar K. What bariatric surgery can teach us about glucagon-like peptide-1 agonist weight loss therapy: Improving long-term outcomes and patient care. World J Clin Cases 2026; 14(20): 121701
|
| URL |
https://www.wjgnet.com/2307-8960/full/v14/i20/121701.htm |
| DOI |
https://doi.org/10.12998/wjcc.121701 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
